Baseline serum folic acid as a prognostic biomarker in metastatic renal cell carcinoma treated with targeted therapy.
Saved in:
| Title: | Baseline serum folic acid as a prognostic biomarker in metastatic renal cell carcinoma treated with targeted therapy. |
|---|---|
| Authors: | Aktepe OH; Department of Medical Oncology, Dokuz Eylul University, Izmir, 35330, Turkey. oktayhalit.aktepe@deu.edu.tr., Izgor RB; Department of Internal Medicine, Dokuz Eylul University, Izmir, Turkey., Ulasli T; Department of Medical Oncology, Dokuz Eylul University, Izmir, 35330, Turkey., Unek IT; Department of Medical Oncology, Dokuz Eylul University, Izmir, 35330, Turkey., Atag E; Department of Medical Oncology, Dokuz Eylul University, Izmir, 35330, Turkey., Semiz HS; Department of Medical Oncology, Dokuz Eylul University, Izmir, 35330, Turkey., Karaoglu A; Department of Medical Oncology, Dokuz Eylul University, Izmir, 35330, Turkey., Erman M; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Yalcin S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. |
| Source: | Discover oncology [Discov Oncol] 2026 Mar 10; Vol. 17 (1). Date of Electronic Publication: 2026 Mar 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-026-04798-4 |
